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Introduction
During early pregnancy, the mammalian endometrium responds to changing ovarian hormones and sig-
naling cues from embryos. The endometrium undergoes extensive growth and differentiation to become 
appropriately receptive to the incoming blastocysts for implantation (1, 2). Commonly referred to as the 
“window of  implantation,” these complex endometrial events must happen in rapid succession in a short 
time frame in order to achieve a receptive phase. In the mouse, the implantation window starts the morning 
of  3.5 days post coitum (dpc; 0.5 dpc = 1200 hours of  the day of  vaginal plug), when fertilized eggs com-
plete their development through the blastocyst stage and descend into the uterus. By this time, the receiv-
ing luminal epithelium (LE) ceases proliferation and initiates differentiation under the influence of  rising 
progesterone (P4) and a small estradiol (E2) surge, whereas the underlying stromal cells undergo extensive 
proliferation and start to differentiate into morphologically and functionally distinct decidual cells. Toward 
the evening of  4.5 dpc, the implantation window closes and the uterus enters the refractory phase, during 
which time the embryos cannot implant. The rapid uterine changes that define the implantation window 
are tightly regulated by a network of  signaling pathways orchestrated by hormones, growth factors, cyto-
kines, and transcription factors. The importance of  uterine receptivity genes is evidenced by the severe 
implantation and/or decidualization defects that occur in response to loss-of-function mutations (3–10).
Retinoic acid (RA), a physiologically active metabolite of its inactive precursor retinol (vitamin A), is 
essential for many biological processes, including cell survival, differentiation, and apoptosis (11). Vitamin A 
deficiency, as well as genetically disrupting RA function, leads to defects in the development of many organs 
and tissues, including the nervous system, kidney, skeleton, heart, lung, and urogenital tracts (12). RA exerts its 
biological functions mainly through binding to the nuclear RA receptors (RARs) facilitated by the cellular reti-
noic acid–binding proteins (CRABPs) or, less frequently, to the noncanonical peroxisome proliferator–activated 
receptor β/γ (PPARβ/γ) facilitated by fatty acid–binding protein 5 (FABP5). The ratio of intracellular lipid-bind-
ing proteins CRABP2 to FABP5 tips the balance toward 1 signaling pathway or the other, which frequently has 
Retinoic acid (RA) signaling has long been speculated to regulate embryo implantation, because many 
enzymes and proteins responsible for maintaining RA homeostasis and transducing RA signals are 
tightly regulated in the endometrium during this critical period. However, due to a lack of genetic data, 
it was unclear whether RA signaling is truly required for implantation and which specific RA signaling 
cascades are at play. Herein we utilize a genetic murine model that expresses a dominant-negative 
form of RA receptor (RAR) specifically in female reproductive organs to show that functional RA 
signaling is fundamental to female fertility, particularly implantation and decidualization. Reduction 
in RA signaling activity severely affects the ability of the uterus to achieve receptive status and 
decidualize, partially through dampening follistatin expression and downstream activin B/bone 
morphogenetic protein 2 signaling. To confirm translational relevance of these findings to humans, 
human endometrial stromal cells (hESCs) were treated with a pan-RAR antagonist to show that in 
vitro decidualization is impaired. RNA interference perturbation of individual RAR transcripts in 
hESCs revealed that RARα in particular was essential for proper decidualization. These data provide 
direct functional evidence that uterine RAR-mediated RA signaling was crucial for mammalian 
embryo implantation, and its disruption led to failure of uterine receptivity and decidualization, 
resulting in severely compromised fertility.
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opposing effects (13). Both RARs and PPARs form heterodimers with retinoid X receptors (RXRs), and they 
regulate target gene expression by directly binding to RA response elements (RAREs) and peroxisome prolifer-
ator response elements, respectively. In addition to these 2 signaling cascades, RA can also bind to cytoplasmic 
RARs and trigger rapid kinase phosphorylation, which in turn regulates downstream signaling events (14).
Previous studies have implicated RA signaling in regulating female fertility. In both the rodent and human 
endometrium, expressions of  RA-synthesizing (aldehyde dehydrogenase and retinaldehyde dehydrogenase) 
and -metabolizing enzymes (CYP26), as well as RA-binding proteins that regulate its bioavailability (CRBPs/
CRABPs/FABP5), are temporally and spatially controlled during early pregnancy (15–17), suggesting their 
involvement in uterine receptivity and embryo implantation. In addition, high expression of  RA signaling 
receptors, including RARs, PPARβ/γ, and RXRs, has been reported at implantation sites of  human and 
rodent endometrium (17–19). In cultured human endometrial stromal cells (hESCs), gene silencing of  
CRABP2 and FABP5 by siRNA inhibits and promotes decidualization, respectively (20), suggesting that RA/
RAR signaling favors decidualization. In seemingly contradictory in vitro data, treatment of  RA at pharma-
cological levels in hESC culture appears to impair decidualization (17, 21). Given the complex genomic and 
nongenomic downstream events elicited by RA in various tissues and the absence of  any uterine data from 
genetic animal models, the definitive role of  RA signaling in implantation requires clarification.
In the current study, we utilized a previously characterized mouse strain that carries the RaraT403 trun-
cated form of human RARα knocked in to the Rosa26 locus to dissect the role of  RA/RAR signaling in 
embryo implantation (22). Cre-mediated recombination removes the floxed-STOP sequence upstream of  
the RaraT403, resulting in expression of  the dominant-negative form of RARα (hereinafter referred to as 
RaraDN), and subsequent inhibition of  endogenous RAR-mediated transcriptional regulation of  target genes. 
We showed that functional RAR signaling is required for mammalian uterine receptivity and decidualization 
both in the mouse model and in cultured hESCs.
Results
RaraDNPgr females are severely subfertile. To generate mice with disrupted RA signaling in the female reproduc-
tive tracts, RaraDNfl/+ mice were mated to Pgr-Cre mice, resulting in offspring females carrying both alleles 
(RaraDNfl/+; Pgr-Cre, hereafter referred to as RaraDNPgr) and littermate controls (CTRLs; no Pgr-Cre). Pgr-
Cre–mediated gene recombination in the uterus is first detected in the luminal and glandular epithelia starting 
at 2 weeks of  age, and gradually expands to the stroma and myometrium (23). To assess disruption of  RAR 
signaling, we examined the expression of  several Hox genes, known direct downstream targets of  RAR, in 
the uteri of  ovariectomized CTRL and RaraDNPgr mice (Supplemental Figure 1; supplemental material avail-
able online with this article; https://doi.org/10.1172/jci.insight.150254DS1). Reduction in expression of  the 
majority of  the Hox genes in the RaraDNPgr uteri demonstrates that RAR signaling was successfully disrupted 
in these animals. Female fertility was evaluated by breeding test of  WT males with either RaraDNPgr or CTRL 
females and tracking the number of  litters and pups produced by each female for 200 consecutive days. Of the 
RaraDNPgr females tested, 6 of  7 were completely sterile, producing 0 litters over the span of  7 months (Fig-
ure 1A). The remaining RaraDNPgr female produced only 2 litters, each consisting of  only 1 pup after a long 
hiatus after mating setup (Figure 1, A and B). RaraDNPgr females as a whole are therefore severely subfertile, 
producing significantly fewer litters and pups than CTRLs (Table 1; P = 9.8 × 10–9 and 7.2 × 10–9, respectively, 
n = 5 for CTRL and n = 7 for RaraDNPgr). No apparent developmental and behavioral abnormalities were 
observed in the 2 pups born to the RaraDNPgr sterility escapee. Vaginal plugs were consistently observed in the 
RaraDNPgr females, ruling out the possibility of  behavioral issues preventing mating. As these females never 
presented palpable pregnancies, early-stage pregnancy defects were suspected.
RaraDNPgr females exhibit implantation defects. Mouse embryo implantation occurs between 3.5 and 4.5 dpc, 
when blastocysts attach to the LE, which in turn triggers the underlying stromal cells to undergo decidual-
ization. Successful implantation is accompanied by increased local vascular permeability, which can be visu-
alized by tail vein injection of  Chicago blue dye. Distinct blue dots indicating implantation sites were easily 
detectable along the uterine horns of  CTRL mice on 4.5 dpc (Figure 1D, arrows, 9.7 ± 2.1, n = 3) but were 
completely absent in the RaraDNPgr uteri (Figure 1, C and E; 0.0 ± 0.0, n = 3, P = 0.0013).
Many factors, alone or in combination, can contribute to failed pregnancy at an early stage, including 
abnormal ovulation, irregular ovarian hormone levels, and poor uterine receptivity. Because Pgr-Cre is also 
active in the adult ovary, including corpora lutea and human chorionic gonadotropin–stimulated granulosa 
cells (23), it is essential to investigate whether disturbance of RA signaling affects ovarian functions. Evaluation 
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of the RaraDNPgr ovaries on 3.5 dpc revealed normal histology with presence of multiple corpus lutea, which 
are the remnants of successfully matured vesicular follicles after ovulation (Supplemental Figure 2, A and B). 
Morphologically normal blastocysts were recovered from RaraDNPgr females by flushing the oviducts and uter-
ine horns on 3.5 dpc (Supplemental Figure 2A, inset), and no significant difference was observed in the number 
of retrieved blastocysts at this stage (Supplemental Figure 2C; CTRL 8.5 ± 3.5, n = 3; vs. RaraDNPgr 6.5 ± 2.1, 
Figure 1. Impaired female fertility due to implantation failure in RaraDNPgr mice. (A) Cumulative number of pups produced by individual CTRL (green) and 
RaraDNPgr females (red) over the period of 200 days. (B) Average number of pups per litter produced by the females presented in A. (C and D) Representative 
images of visualization of implantation sites (arrows) by Blue Dye injection on 4.5 dpc. (E) Quantification of implantation sites from CTRL (9.7 ± 2.1, n = 3) 
and RaraDNPgr females (0.0 ± 0.0, n = 3, P = 0.0013). (F and G) H&E staining of RaraDNPgr and CTRL uteri on 3.5 dpc. (H and I) Immunofluorescence detecting 
pHH3-positive proliferating cells on 3.5 dpc (arrowheads, uterine epithelial cells; arrows, proliferating stromal cells; dashed lines outline the luminal epithelia). 
(J and K) CDH1 immunofluorescence on 3.5 dpc uterine sections. Note in the CTRL, reduced CDH1 level is obvious in the luminal epithelium (J, arrowheads) 
when compared with glandular epithelium (J, arrows), whereas this difference is negligible in RaraDNPgr uterus (K). (L and M) Gene expression on 3.5 dpc deter-
mined by qRT-PCR, normalized to levels of housekeeping gene Rpl7 and the average transcript level of CTRL samples was set to 1. (N and O) RNAscope in situ 
hybridization of Foxo1 showing elevated transcript level in the mutant epithelium. (P–S) IF staining of ESR1 (P and Q) and PR (R and S) revealed no apparent 
differences in expression. *P < 0.05; ns. Scale bars: 50 μm. CTRL, controls; dpc, days post coitum; O, ovaries; g, glands; l, lumen; IF, immunofluorescence; 
pHH3, phospho-histone H3; ESR1, estrogen receptor 1; PR, progesterone receptor.
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n = 3, P = 0.27), indicating normal fertilization rates. In addition, evaluation of serum ovarian hormone levels 
at this stage by ELISA revealed no significant differences (Supplemental Figure 2D). Together these data indi-
cate normal ovarian function in RaraDNPgr females.
RaraDNPgr females exhibit uterine receptivity defects. Successful embryo implantation depends on the achieve-
ment of  uterine receptivity through a series of  molecular, hormonal, and morphological changes. In the 3.5 
dpc mouse uterus, the LE typically ceases proliferation under the influence of  decreased E2 and P4 levels to 
prime for rapid remodeling and embryo embedding (24). Meanwhile, luminal epithelial cells turn off  genes 
for apical–basal polarity like Cadherin1 (CDH1, also known as E-cadherin) to allow attachment of  tropho-
blast cells to their apical pole (25). To assess the status of  uterine receptivity, we first examined gross uterine 
morphology at this stage and found no overt abnormalities except for aberrant luminal closure (Figure 1, F 
and G). Uteri of  CTRL 3.5 dpc females exhibited typical signs of  receptivity, i.e., halted epithelial prolifera-
tion evidenced by limited phospho-histone H3 staining (Figure 1H) and reduced CDH1 expression exclusive-
ly in the LE (Figure 1J, arrowheads). By contrast, the RaraDNPgr uteri sustained high LE proliferating activity 
(Figure 1I, arrowheads) and high CDH1 expression (Figure 1K, arrowheads) in the LE, consistent with a 
prereceptive or nonreceptive uterus.
Quantitative RT-PCR (qRT-PCR) was performed to further interrogate expression of  genes involved in 
uterine receptivity. Amphiregulin (Areg), a member of  the epidermal growth factor family, is upregulated 
exclusively in the uterine epithelium on 3.5 dpc surrounding the embedding embryos in a P4-dependent man-
ner (26). This upregulation was absent in the RaraDNPgr mutant (Figure 1L). Expression of  early growth 
response gene 1 (Egr1), a zinc finger transcription factor that is crucial for cell proliferation and angiogene-
sis, was previously reported to be induced in the subluminal stroma surrounding the blastocysts (27), but it 
is barely detectable in the mutant uterus on 3.5 dpc. Previous studies in ovarian hormone-responsive cells 
including uterine epithelial cells have shown that E2 signaling can promote LE cell proliferation by transacti-
vating expression of  the cell cycle gene cyclin D1 (Ccnd1), as well as facilitating its nuclear translocation (28, 
29). RaraDNPgr uteri exhibit a marked increase in Ccnd1 mRNA, which may contribute to the mutant’s aber-
rant epithelial proliferation. Deregulation of  transcription factors essential for uterine receptivity and embryo 
implantation was also evident in the RaraDNPgr uteri on 3.5 dpc, including those expressed in the epithelial 
compartment, such as Forkhead Box O1 (Foxo1; ref. 30), and those exclusively expressed in the stroma, such 
as Homeobox A10 (Hoxa10; ref. 31). RNAscope in situ hybridization of  Foxo1 revealed that its elevation in 
the mutant is confined to the uterine epithelium (Figure 1, N and O). In addition, analysis of  a subset of  gold 
standard receptivity biomarkers used in customized endometrial receptivity arrays for clinical endometrial 
evaluation in humans (32, 33) revealed markedly reduced expression of  many receptivity biomarkers in the 
RaraDNPgr uteri during the periimplantation period (Supplemental Figure 3). Even though many of  these 
genes have been reported to be regulated by ovarian hormones, the changes we observed in the RaraDNPgr 
mutant are unlikely to be elicited solely by altered hormone signaling, because serum ovarian hormone level 
(Supplemental Figure 2) as well as uterine expression of  ovarian hormone receptors and some of  their well- 
established targets remained unchanged (Figure 1M). Immunofluorescence of  estrogen receptor 1 (ESR1) 
and progesterone receptor (PR) further confirmed that the ovarian hormone receptors were expressed at nor-
mal locations and levels in RaraDNPgr females comparable to their WT counterparts (Figure 1, P–S).
Decidualization is compromised in RaraDNPgr females. Despite the absence of luminal closure, which is thought 
to help immobilize the embryos for implantation, blastocyst attachment appears to successfully occur in the 
RaraDNPgr uteri on 4.5 dpc (Figure 2, B and D, compared with Figure 2, A and C), raising the possibility that 
failures in subsequent pregnancy events also contribute to the fertility defects. As we and others have previously 
reported (34, 35), during embryo attachment, strong CDH1 expression is present only in the apical poles of  
the uterine epithelium and barely detectable on the basal side (Figure 2C, arrows). Interestingly, this polarized 
Table 1. The 200-day breeding record









CTRL 5 311 62.2 34 6.8
RaraDNPgr 7 2 0.286 2 0.286
CTRL, control. 
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localization of CDH1 is absent in the RaraDNPgr uteri; strong CDH1 staining was observed on both sides (Fig-
ure 2D, arrowheads). After embryo attachment, fibroblastic uterine mesenchymal cells undergo decidualiza-
tion. Decidualization is the rapid proliferation and differentiation of these cells into morphologically distinct 
decidual cells, which provide a plethora of growth factors and cytokines to support embryo development and 
serve an immunoregulatory role during early pregnancy. To investigate whether decidualization is affected 
in the RaraDNPgr females, we first examined the expression of known decidualization markers during natu-
ral pregnancy in these mutants. Transcription factor heart and neural crest derivatives expressed transcript 2 
(HAND2) plays a critical role in uterine receptivity and decidualization in the mouse, and its expression is 
induced in endometrial stromal cells starting on 3.5 dpc and increases over time (7, 36). It modulates stromal–
epithelial communications through negative regulation of FGF signaling and genetic ablation of Hand2 in the 
mouse lead to female infertility largely due to decidualization failure (7, 36). Immunofluorescence revealed 
that HAND2 protein exhibited nuclear localization in the CTRL subepithelial stromal cells on 4.5 dpc (Figure 
2E, arrows), but its level was dramatically reduced and its nuclear localization undetectable in the mutant 
uterus (Figure 2F). This reduction in Hand2 levels was confirmed at the transcript level by qRT-PCR using 
RNA extracted from whole uterine tissues on 4.5 dpc (Figure 2G). Expression of an array of genes involved 
in decidualization was evaluated by qRT-PCR, and mutant uteri exhibited significant decreases in the major-
ity of them, including Add2, Ereg, Gata2, Hbegf, Hsd11b1, Igfbp1, Lcn2, Prl, and Wnt4. Lpar3, a gene encoding 
lysophosphatidic acid receptor 3, a G protein–coupled receptor for lysophosphatidic acid that fine-tunes the 
local balance of P4 and E2 signaling during implantation, is highly expressed in the 3.5 dpc uterus and sharply 
shut down at 4.5 dpc during normal implantation (37, 38). In the mutant 4.5 dpc uterus, Lpar3 transcript level 
remained high, consistent with the failed implantation observation. Together these results demonstrate a decid-
ualization failure in RaraDNPgr females in the setting of natural pregnancy.
To rule out the potential involvement of defective embryo attachment and/or defective hormone regulation 
as a cause for decidualization failure, we performed an artificial decidualization assay. In mice, decidualization 
of uterine stromal cells can be achieved by intraluminal oil injection into the uterine horns of ovariectomized 
Figure 2. Failure of decidualization in 4.5 dpc RaraDNPgr uterus. (A and B) H&E staining of RaraDNPgr and CTRL uteri on 4.5 dpc. (C and D) CDH1 immunofluo-
rescence on 4.5 dpc uterine sections. Note the presence of normal blastocyst in the mutant lumen (D), and persistent high CDH1 level in the underlying luminal 
epithelium, especially at the basal side (arrowheads, compared with CTRL arrows in C). (E and F) Immunofluorescence detection of HAND2 protein in the nuclei of 
decidual cells in the CTRL (arrows, E), which is absent in the mutant (F). (G) Relative transcript levels of genes involved in decidualization by qRT-PCR. Scale bars: 
50 μm. *P < 0.05. dpc, days post coitum; CTRL, control; l, lumen; b, blastocyst; CDH1, cadherin1; HAND2, heart and neural crest derivatives expressed transcript 2.
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and hormone-primed females followed by additional hormone treatments after induction. As shown in Figure 
3, A and B, disruption of RA signaling in RaraDNPgr uteri renders them nonresponsive to decidual stimuli. Uter-
ine weight gain due to stimuli was completely abolished (Figure 3C), and differentiation markers like Igfbp1, Prl, 
and alkaline phosphatase (AP) failed to be induced in the mutant uteri (Figure 3, D–F). Genes encoding RARs 
as well as some known downstream RAR signaling targets showed differential expression in stimulated mutant 
uteri relative to CTRLs (Figure 3G). Significant reduction in transcript levels were observed in the mutants for 
RARs Rara, Rarb, Rxra, and Rxrg, as well as RA targets Cdx1, Gbx2, Mmp9, and Prrx2. On the other hand, stim-
ulated mutant uteri exhibit drastic increases in mRNA levels for transcription factors Msx1 and Sox17 relative 
to CTRL decidua. Expression of Msx1 was previously reported to sharply decline after embryo attachment to 
prepare the uterus for implantation by modulating WNT and FGF signaling between the epithelial and stromal 
compartments (39). In addition, persistent Msx1 expression was shown to be associated with uterine receptivity 
defects observed in Lif–/– mice (40). Sox17 also plays critical roles during implantation through modulating the 
uterine transcriptome (41). Most of the genes assayed including some of the RARs (Figure 4A) and their down-
stream targets (Figure 4B) displayed the same trend of expression changes during the periimplantation period 
of natural pregnancy in RaraDNPgr uteri. These findings provide further support that disrupted expression of  
RAR downstream targets likely contributed to the decidualization defect observed in the RaraDNPgr mutants. 
We stress, however, that at present we cannot exclude the possibility that the decidualization defect in these 
mutants was secondary to the observed uterine receptivity defect. Tissue-specific ablation of RA signaling in the 
implanting uterus is required to address this point.
Disrupted RAR-signaling leads to reduced follistatin and aberrant activin signaling. During gene expression anal-
ysis, we observed a striking decrease in the expression of  follistatin (Fst) in the RaraDNPgr on 3.5 dpc (Figure 
5A). This is of  particular interest because previous studies revealed that Fst is a direct transcriptional target of  
RA signaling, containing RAREs in its promoter region (42). Additionally, Pgr-Cre–mediated genetic deletion 
of  Fst leads to female fertility defects very similar to our RaraDNPgr mutants (43). Accompanying the sharp 
reduction of  Fst, expression of  inhibin βb (Inhbb), components of  activin B and downstream target of  FST sig-
naling, was significantly upregulated (Figure 5A). In the uterine-specific Fst knockout model, absence of  FST 
Figure 3. RaraDNPgr mutant uterus does not respond to artificial decidualization stimuli in vivo. (A and B) Representative 
images of artificially decidualized uteri 5 days after stimulation. Arrows indicate the uterine horn that received intrauterine 
oil infusion; contralateral horns serve as controls. (C) Uterine weight ratio (wet weight stimulated/wet weight unstim-
ulated) was calculated for each animal, and graphed as mean ± SD (CTRL, 7.1 ± 2.4, n = 8; RaraDNPgr, 1.4 ± 2.4, n = 5; P = 
0.00036). (D) Gene expression data of decidualization markers, Igfbp1 and Prl, in the stimulated uterine horn by qRT-PCR. 
(E and F) AP activity in the stimulated uterine horns visualized by dark color development from AP substrate BCIP/NBT. (G) 
Gene expression analyses of RARs and RAR targets comparing RNA extracted from stimulated CTRL and RaraDNPgr uteri by 
qRT-PCR. *P < 0.05. Scale bars: 50 μm. CTRL, control; AP, alkaline phosphatase; RA, retinoic acid; RAR, RA receptor.
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and elevated activin B activity caused reduction in BMP signaling, especially BMP2, through the activin/
SMAD signaling pathway (43). In line with this notion, we observed a similar reduction in Bmp2 expression 
on 4.5 dpc (Figure 5B), as well as reduction in phospho-SMAD1/5/8 (Figure 5C) in RaraDNPgr mutants. 
RNAscope in situ hybridization was performed, which further confirmed the reduction of  Fst and Bmp2 in 
RaraDNPgr uterus. Fst transcript was detected throughout the CTRL uterus on 3.5 dpc (Figure 5D) but was 
barely detectable in the mutant (Figure 5E). Bmp2 transcript was detected exclusively in the subepithelial 
stromal cells in CTRL uterus on 4.5 dpc (Figure 5F), and its expression was markedly reduced in the mutant 
(Figure 5G). If  the fertility defects observed in the RaraDNPgr mice are indeed caused primarily by the loss 
of  Fst expression, one would expect the phenotype to be alleviated when FST is supplemented back to the 
mutant uterus. To test this hypothesis, we isolated uterine stromal cells from 2.5 dpc mutants for in vitro cul-
ture and added recombinant mouse FST to the medium at various concentrations. Forty-eight hours after cul-
ture, expression of  several decidualization markers is elevated by addition of  FST; for Bmp2 and Igfbp1 these 
changes are dose-dependent (Figure 5H). Similar restoration of  decidual marker expression were observed in 
a uterine organ culture system where either BSA-soaked or FST-soaked agarose beads were inserted into the 
lumens of  2.5 dpc RaraDNPgr uterine segments and allowed to culture in vitro for 2 days (Figure 5I). To test 
whether FST is sufficient to rescue the mutant implantation defects in vivo, FST was administered systemical-
ly into 2.5 dpc RaraDNPgr females via tail vein injection. On 6.5 dpc, bulging regions along the uterine horns 
resembling implantation sites were observed in these mutants (Figure 5J), although they appeared smaller 
than normal implantation sites at this developmental stage. Sections through the bulging regions revealed 
elevated Bmp2 and Hand2 transcripts (Figure 5, K and L, respectively), as well as extensive AP activity (Figure 
5M), indicating restored decidualization in the mutant by FST administration. However, histological analyses 
did not reveal any uterine closure or embryo presence, suggesting that other aspects of  implantation, most 
likely uterine receptivity, could not be rescued by FST alone. This partial rescue was observed in 2 of  3 RaraD-
NPgr females tested, with 2 and 3 bulging sites in each animal, respectively. These data together demonstrate 
that RARs regulated uterine decidualization mainly through FST.
Figure 4. Changes in expression of RAR genes and known RAR targets in the RaraDNPgr uterus during the periimplantation period. Gene expression by 
qRT-PCR performed on whole uterine RNA extract on 3.5 and 4.5 dpc detecting RARs (A) and targets (B). *P < 0.05 comparing CTRL uteri of same time 
point. RAR, retinoic acid receptor; dpc, days post coitum; CTRL, control.
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RAR signaling is essential for decidualization in hESCs. In our previous study, we engineered a fluorescent 
reporter hESC line and performed genome-wide siRNA screening to identify genes required for normal decid-
ualization (44). A total of  136 genes involved in the RA pathway were among the hits, including 29 upstream 
and 107 downstream of RAR signaling (Supplemental Figure 4). To investigate the role of  RAR signaling in 
human endometrium, we performed individual siRNA knockdown against the 3 human RAR genes (RARA, 
RARB, and RARG) in hESCs. In particular, knocking down RARA significantly inhibited in vitro decidualiza-
tion of  the hESCs, evidenced by a decreased expression of  decidualization markers IGFBP1 and PRL (Figure 
6A). Successful knockdown of individual RAR genes was confirmed by qRT-PCR (Figure 6B). Interestingly, 
siRNA against RARA not only reduced RARA expression by more than 80% but also simultaneously resulted 
in significant increases in RARB and RARG expression, likely due to a compensatory signaling feedback loop 
(Figure 6B). By contrast, knocking down RARB or RARG did not affect hESC decidualization, nor did it elicit 
significant changes in the expression of  other RAR genes (Figure 6, A and B).
To further dissect the involvement of  RAR genes in implantation, we evaluated the expression of  RAR 
genes by qRT-PCR in both mouse uterus during the periimplantation period and decidualized hESCs. As 
Figure 5. Reduced follistatin expression and downstream changes in activin/BMP signaling are partially responsible for the fertility defects in RaraDNPgr 
uterus. (A and B) Relative expression levels of Fst and Inhbb on 3.5 dpc (A) and Bmp2 on 4.5 dpc (B). (C) Western blot for phospho-Smad1/5/8 of whole uteri 
extract from CTRL and RaraDNPgr females on 3.5 dpc. Western blot band density was quantified in ImageJ (NIH), and the relative density calculated as the 
ratio of pSMAD/GAPDH for each sample was listed. (D–G) RNAscope in situ hybridization of Fst on 3.5 dpc (D and E) and Bmp2 on 4.5 dpc (F and G). Positive 
results manifest as red staining; dotted lines outline the luminal epithelium. (H) Gene expression of decidualization markers in isolated endometrial stromal 
cells from 2.5 dpc RaraDNPgr uteri treated with recombinant mouse FST at indicated concentrations for 48 hours (n = 2). (I) Gene expression of decidualization 
markers in uterine segments dissected from 2.5 dpc RaraDNPgr and incubated with luminal agarose beads soaked with BSA or FST for 2 days (n = 2). (J) Appear-
ance of RaraDNPgr mutant uteri 4 days after receiving 2 μg FST via tail vein injection (arrows point to bulging regions resembling implantation sites). (K and L) 
RNAscope in situ hybridization of Bmp2 (K) and Hand2 (L) showed elevated expression in the bulging region. (M) BCIP/NBP staining of bulging regions shows 
extensive alkaline phosphatase activity. Asterisks indicate P < 0.05 by t test; a indicates P < 0.05 by 1-way ANOVA between drug group and control group; and 
b indicates P < 0.05 by 1-way ANOVA between different doses. Scale bars: 50 μm. dpc, days post coitum; CTRL, control; BMP, bone morphogenetic protein 2.
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shown in Supplemental Figure 5, in both model systems, Rara/RARA and Rarg/RARG were the most abun-
dant isotypes among the Rar/RAR genes, whereas Rxra/RXRA and Rxrb/RXRB were the predominantly 
expressed Rxr/RXR genes. Hormonal regulation of  the receptor genes was also examined in cultured hESCs 
(Supplemental Figure 6). Twenty-four hours of  exposure to medroxyprogesterone acetate (MPA) elevated 
RARA transcript level, and this effect was augmented by cotreatment of  E2 plus MPA, even though E2 alone 
did not elicit any changes. RXRB, on the other hand, was induced and suppressed by E2 and MPA, respec-
tively, and cotreatment appears to have counteracted each other and canceled out the effect. The expression 
levels of  the other RAR and RXR genes were not affected by hormone treatment within this time frame.
To further demonstrate dependency of human decidualization on RA signaling, hESCs were treated with 
a pan-RAR antagonist, AGN194310 (45), at increasing concentrations. As shown in Figure 6C, both decidu-
alization markers IGFBP1 and PRL exhibited a dose-dependent decrease in expression upon drug treatment. 
The expression of endogenous RAR genes, including RARA, RARG, RXRA, and RXRB, also exhibited dose- 
dependent reductions in response to AGN194310 (Figure 6D). Taken together, these results strongly support 
the notion that RAR signaling, particularly through RARA, was required for in vitro decidualization of hESCs.
Discussion
In the current study, we generated and characterized a mouse model with conditional disruption of  RA/
RAR signaling specifically in female reproductive organs. The dominant-negative RaraDN allele used in 
this study has been previously shown to block endogenous RAR-dependent signaling through competitively 
binding to RAREs (22). The vast majority of  females carrying only 1 copy of  the RaraDN allele in Pgr- 
cre–expressing cells are sterile, whereas 1 is severely subfertile, due to defective uterine receptivity and decid-
ualization. Given that the dominant negative receptor blocks RAR signaling in a dose-dependent manner, 
and that having 2 alleles of  RaraDN completely abolishes endogenous RA signaling (22), we expect the 
detrimental effects on female fertility would be more severe in Pgr-cre RaraDNfl/fl females. Our findings also 
Figure 6. RAR signaling is essential for decidualization of hESCs. (A and B) Gene expression by qRT-PCR of human decidualization markers (A) and RAR 
genes (B) when individual RAR genes are silenced by siRNA. (C and D) Expression of decidualization markers (C) and selective RAR and RXR genes (D) 
when hESCs are treated with pan-RAR antagonist AGN194310 at indicated concentrations. Asterisks indicate P < 0.05 by t test; a indicates P < 0.05 by 
1-way ANOVA between drug group and control group; and b indicates P < 0.05 by 1-way ANOVA between different doses.
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indicate that RA signaling through PPARβ/γ and/or nongenomic pathways could not compensate for the 
loss of  RAR signaling during implantation.
Even though Pgr-cre also mediates RaraDN expression in the ovary, there is no indication that the mutant 
ovaries are affected. Not only do ovarian hormone levels remain unchanged in these mutants, but ovulation 
and fertilization also occur normally. Consistent with our data, genetic ablation of  all 3 Rar genes as well as 
that of  all 3 RA synthesis enzymes (Aldh1a1–3) in the developing mouse ovary does not affect ovary differenti-
ation or ovarian function (46). RAR signaling endogenous to the embryos also does not appear to be required 
for uterine receptivity or decidualization, as transgenic embryos carrying the RaraDN allele driven by an 
SV40 early promoter implant and develop to term when transferred into WT recipient dams (47).
In the absence of  ligand, RAR/RXR heterodimers can actively repress target genes by occupying RAREs 
and complexing with corepressor proteins, such as nuclear receptor corepressor (NCoR) and silencing medi-
ator of  retinoic acid (SMRT), to prevent transcription (48–50). The presence of  RA induces conformational 
changes in the ligand-binding domain of  RARs, resulting in simultaneous attenuation of  affinity for core-
pressors and increased affinity for coactivators, including histone acetyltransferases and DRIP/TRAP/ARC 
coactivators and other mediator-containing complexes, to decompress chromatin and transactivate target 
genes (51–53). Rapid repression of  target genes upon RA signaling activation has also been reported exten-
sively (54–56); however, the molecular mechanism is less studied. It is believed that liganded heterodimers 
recruit polycomb repressive complex 2, histone deacetylase, and coregulator(s) to actively inhibit target gene 
transcription, but the identity of  the coregulator(s) remains unknown. Even though the 3 RAR genes share 
extensive homology, and in many cases function redundantly, unliganded heterodimers RXR/RARβ and 
RXR/RARγ interact with SMRT corepressors differently from unliganded heterodimers of  RXR/RARα 
by mediating a substantial level of  transactivation rather than repression (57). The RaraDN mutant receptor 
used in this study lacks the carboxyl terminal sequence of  the human RARA gene but is also highly efficient 
at inhibiting the other 2 receptors (47). Dose-dependent blocking of  transcription activation by this recep-
tor has been demonstrated in various RARE-reporters both in vitro and in vivo (22, 47, 58); however, little 
is known about its impact on relieving repression or active inhibition of  target genes. In the current study, 
we identified genes that are activated or repressed during the periimplantation window in RaraDNPgr uterus, 
suggesting both instructive and permissive roles of  RAR signaling. Whether these genes were direct transcrip-
tional targets of  RAR signaling or their expression reflected a manifestation of  changes in a cohort of  “master 
RAR targets” demands further investigation.
In this study, we report that the receptivity and decidualization defects in the RaraDNPgr uterus were partially 
caused by loss of Fst expression. FST, also known as activin-binding protein, is a glycoprotein that regulates 
TGF-β superfamily signaling, primarily through binding to activin (59). Activin B, homodimer of Inhibin βB, 
binds to and activates ACVR2A/B and ALK4/7 and in turn phosphorylates SMAD2/3. Fst is upregulated 
during periimplantation in the mouse uterus, which is believed to sequester activin B in order to allow BMP 
signaling activation (43). Genetic ablation of Fst leads to severe female subfertility in mice with receptivity and 
decidualization defects similar to RaraDNPgr mice (43), and aberrant expression of FST and activins are associ-
ated with poor pregnancy outcome in patients undergoing in vitro fertilization (IVF; ref. 60). In RaraDNPgr mice, 
greatly reduced Fst expression was accompanied by increased Inhbb expression on 3.5 dpc and loss of Bmp2 
induction on 4.5 dpc. Interestingly, the loss of Bmp2 and deregulation of other decidualization markers were par-
tially rescued by supplementation of FST protein in isolated mutant endometrial stromal cells, in organ culture, 
as well as in vivo, suggesting that loss of FST can largely account for the severity of decidualization defects in 
RaraDNPgr mice. However, Fst downregulation is unlikely to be the sole reason for the mutant impaired fertility 
for 3 reasons. First, gene expression changes in the RaraDNPgr mutants including a wide array of known RA tar-
gets were evident that have no known link to the FST and activin signaling pathway. Second, the fertility defects, 
especially in terms of decidualization, are much more severe in the RaraDNPgr mutants than in the Fst-cKO mice. 
Finally, not all decidualization genes tested were rescued by FST supplementation, e.g., Prl. Thus, although FST 
is an important downstream component of decidual RAR signaling, and although it is likely a direct RAR tran-
scriptional target (42), our findings suggest that a wider network of signaling pathways was at play. Interestingly, 
the regulation of BMPs by RAR signaling has been reported in other cellular contexts. In the mouse testicular 
embryonal carcinoma cell line, RA induces Bmp2 while simultaneously repressing Bmp4, specifically through 
RARα and RARγ (61). In primary bone marrow stromal cultures, the addition of retinaldehyde stimulates Bmp2 
expression, and this induction is dampened by cotreatment of RAR antagonist AGN193109 (62). Whether the 
regulation of BMPs by RAR signaling is also mediated by FST in these specific cell types is not clear.
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In addition to the mouse data, we also demonstrated the requirement of RAR signaling, specifically 
through RARα, in hESC decidualization. Knocking down RARA in hESCs resulted in substantial downregula-
tion of decidualization markers, as well as the elevation of RARB/G, possibly by a compensatory mechanism 
in response to a loss of RARα signaling. Knockdown of RARB/G, on the other hand, had no detectable effects 
on human in vitro decidualization. Treatment of a pan-RAR antagonist also caused a dose-dependent reduc-
tion of decidualization marker expression, as well as the expression of major RAR/RXR genes. Infertility due 
to vitamin A deficiency has been reported in humans, and fertility was restored after carefully titrated supple-
mentation of vitamin A back to normal levels (63). A review of the vitamin A content of the top 25 best-selling 
prenatal vitamins at the United States’ top-grossing online store (Amazon.com) revealed that the percent daily 
value for pregnant and nursing individuals ranges from 0% to 185% from a variety of precursors, with the 
best seller having no vitamin A (Supplemental Table 1). Extreme excess maternal vitamin A is a documented 
teratogen, although this is shown to be largely from feedback inhibition of native RA production in developing 
embryos (64). Low maternal vitamin A intake can likewise cause birth defects such as diaphragmatic hernia 
(65). The current study adds to the existing body of data to emphasize that not only is it essential for maternal/
fetal health to have biologically appropriate levels of maternal RA, but it is also crucial for uterine receptivity 
and decidualization to have proper RAR signaling, as shown herein in mice in vivo and in hESCs in vitro.
Methods
Mice. Generation of  mice carrying RaraDN preceded by a floxed transcriptional/translational STOP sequence 
was previously described (22), and cryopreserved sperms from mutant mice were provided by Benjamin D. 
Humphreys in the Division of  Nephrology, Washington University School of  Medicine. Live mice carrying 
the RaraDN mutation were rederived via IVF at the Mouse Genetics Core at Washington University. Pgr-Cre 
line was provided by Francesco DeMayo (National Institute of  Environmental Health Sciences, Durham, 
North Carolina, USA; ref. 23) and mated to RaraDNfl/+ mice to generate offspring carrying both alleles (here-
inafter referred to as RaraDNPgr) and littermate CTRLs (RaraDNfl/+). Artificial decidualization and tail vein 
injection were performed following standard procedures as previously described (35, 66, 67). All mice used 
in this study were maintained in a barrier facility at Washington University School of  Medicine following the 
institution’s regulations with an approved protocol.
Uterine stromal cell isolation and organ culture. Uteri of 2.5 dpc mice were collected, rinsed in cold Hank’s 
Balanced Salt Solution (HBSS; Gibco), cut into 2 to 3 mm pieces, and digested in 1% trypsin (MilliporeSigma) 
in HBSS for 1 hour at room temperature with gentle shaking. After incubation, LE of each uterine segment 
was gently squeezed out using fine forceps along the longitudinal axis of the uterus. The remaining uterine 
tissues were transferred to a fresh tube, further digested in 0.25% trypsin and 1 mg/mL collagenase (Milli-
poreSigma) in HBSS for 30 minutes at 37°C with gentle shaking, and dissociated by pipetting several times 
after incubation. Cell suspension and tissue remnants were filtered through a 70 μm nylon filter, and stromal 
cells were resuspended in hESC culture media (phenol red–free DMEM/F12, 7.5% charcoal-stripped FBS, 1× 
nonessential amino acids, 1× antibiotic-antimycotic). Stromal cells were seeded in 12-well plates, and follistatin 
(Sino Biological US Inc) was added to the culture media at indicated concentrations. For organ culture, 2.5 
dpc uteri were cut into 2 to 3 mm segments and placed on the membrane of multiwall inserts. The inserts were 
then placed into 12-well culture plates containing 0.5 mL culture medium, and 10 agarose beads soaked in 100 
ng/μL follistatin (Sino Biological US Inc) or BSA were transferred into the lumen of each segment (68). Both 
primary stromal cells and uterine organ cultures were harvested 48 hours after for RNA isolation.
hESC culture. Immortalized hESCs were previously characterized (69) and purchased from the American 
Type Culture Collection (CRL-4003). hESCs were maintained in hESC culture media plus 1× Insulin/Trans-
ferrin/Selenium (Gibco) in a humidified 37°C incubator supplied with 5% CO2. To induce decidualization 
in vitro, culture medium was replaced with induction medium (hESC medium plus 36 nM 17β-estradiol, 
1 μM medroxyprogesterone/MPA, 0.1 mM cAMP), and hESCs were allowed to decidualize for 96 hours 
before RNA extraction. Gene knockdown experiments were performed using DharmaFECT4 transfection 
reagent (GE Healthcare Dharmacon) and Silencer Select Validated siRNAs (Thermo Fisher Scientific, cata-
log 4427038, RARA, siRNA s11801; RARB, siRNA s534565; RARG, siRNA s11807) following the manufac-
turer’s instructions. The morning after transfection, 10× induction cocktail topper was added to the culture to 
a final concentration of  1×, and cells were cultured for an additional 72 hours before harvest. For RAR antag-
onist treatment, hESCs were treated with induction medium with or without AGN194310 (MilliporeSigma) 
at indicated concentrations for 72 hours, before harvest for RNA extraction.
1 2
R E S E A R C H  A R T I C L E
JCI Insight 2021;6(17):e150254  https://doi.org/10.1172/jci.insight.150254
RNA isolation and real-time RT-PCR. RNA was extracted in RNA STAT-60 reagent following the manu-
facturer’s instructions (Tel Test Inc). Reverse transcription was performed using the High Capacity cDNA 
Reverse Transcription kit (Applied Biosystems), and qPCR was performed on ViiA 7 Real-Time PCR Sys-
tem (Applied Biosystems) using PowerUp SYBR Green Master Mix (Applied Biosystems). All results were 
repeated in 3 biological replicates unless specified and relative gene expression changes were determined by 
ΔΔ Ct method (normalized to housekeeping gene, Rpl7). Primers are listed in Supplemental Table 2.
Histology, immunofluorescence, and alkaline phosphatase activity assay. Tissues fixed in Bouin’s fixative were 
processed for serial dehydration and embedding at the Developmental Biology Histology Core at Washington 
University School of  Medicine. Eight-micrometer paraffin sections were used for H&E staining and immu-
nofluorescence (70). All antibodies were used at 1:1000 dilution in blocking solution (1% BSA, 3% normal 
goat serum in PBS): CDH1 (BD Biosciences), phospho-histone H3 (MilliporeSigma), Alexa Fluor 594 goat 
anti-rabbit, and Alexa Fluor 488 goat anti-mouse (Life Technologies). Paraformaldehyde-fixed paraffin-em-
bedded sections were used for alkaline phosphatase (AP) activity assay. The sections were dewaxed, rehydrat-
ed, and washed in PBS. Rehydrated sections were subsequently incubated in freshly prepared AP staining 
solution containing 0.33 mg/mL nitro blue tetrazolium (Roche) and 0.165 mg/mL 5-bromo-4-chloro-3-indo-
lyl-phosphate (Roche) in AP buffer (100 mM Tris-Cl, pH 9.0, 150 mM NaCl, 1 mM MgCl2) for color devel-
opment. Antibody catalog numbers are listed in Supplemental Table 3.
Ovarian hormone analyses. Whole blood was collected by cardiac puncture and allowed to coagulate in 1.5 
mL Eppendorf tubes at room temperature for 20 minutes. The blood samples were centrifuged at 800g for 10 
minutes at 4°C, and supernatant (serum) aliquoted and stored at –80°C until use. Cayman Chemical ELISA 
kits for detection of E2 (501890) and P4 (582601) were used to determine serum hormone levels following the 
manufacturer’s instructions. Plates were read on a Bio-Rad 3550 microplate reader at the wavelength of 405 
nm, and data were processed in Microsoft Excel and visualized in GraphPad Prism. Four biological replicates 
were tested and presented for each genotype.
In situ hybridization. In situ hybridization was performed on PFA-fixed, paraffin-embedded, 8 μm tissue 
sections using RNAscope 2.5 HD Assay-RED kit (Advanced Cell Diagnostics). Gene-specific double-“Z” oli-
go probes compatible with the kit were ordered from Advanced Cell Diagnostics (probe-Mm-Bmp2, catalog 
406661; probe-Mm-Fst, catalog 454331), and detailed in situ procedure has been previously described (35).
Statistics. All experimental groups contained 3 biological replicates, if  not specified otherwise. Two-tailed 
Student’s t test assuming unequal variance was performed to compare means of  the experimental groups. 
For dose response experiments, 1-way ANOVA with post hoc Tukey’s honestly significant difference test was 
performed. Data are presented as mean ± SD, with raw individual experimental data displayed as dot plot 
overlay, and a P value of  less than 0.05 was considered statistically significant.
Study approval. The animal studies included herein were reviewed and approved by the IACUC of Wash-
ington University. All studies were performed to the current standards of  the American Association for Labo-
ratory Animal Science so as to minimize pain, suffering, and total animals necessary for conclusive findings.
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